BioNumerik Pharmaceuticals Inc.

Several Hybridon Presentations Highlight Early Cancer Platform.
BIOWORLD Today; 11/4/2009; 1460 words; ...that weren't. AVI BioPharma Inc., of Portland, Ore., presented...mice treated with the Neugene. BioNumerik Pharmaceuticals Inc., of San Antonio, presented...taxane and platinum drugs. BioNumerik presented data on the binding...

Inex Presents Interim NHL Trial Results With 100% Response.
BIOWORLD Today; 11/4/2009; 2582 words; ...patient's tumor. AVI BioPharma Inc., of Portland, Ore., presented...development partner, SuperGen Inc., of Dublin, Calif. BioNumerik Pharmaceuticals Inc., of San Antonio, and Grelan Pharmaceutical Co. Ltd., of Tokyo, presented...

BioNumerik Files For IPO To Fund Late-Stage Cancer Drugs.
BIOWORLD Today; 11/3/2009; 1180 words; ...markets, BioNumerik Pharmaceuticals Inc. set out to raise...corporate purposes. BioNumerik, which is in an SEC...Needham & Co. Inc., Leerink Swann...As of March 31, BioNumerik had cash, cash equivalents...and Japan. Grelan Pharmaceutical Co. Ltd., of Tokyo...

Other News To Note.
BIOWORLD Today; 11/3/2009; 1248 words; ...development of an rPA vaccine. o BioNumerik Pharmaceuticals Inc., of San Antonio, withdrew...and development activities. BioNumerik had withdrawn an earlier IPO...June 11, 2004.) o Gene Logic Inc., of Gaithersburg, Md...

Publication No. WO/2009/113984 Published on Sept. 17, Assigned to BioNumerik Pharmaceuticals for Chemoprotective Method, Composition (American Inventor)
US Fed News Service, Including US State News; 9/19/2009; 410 words; ...Hausheer, the U.S., has developed chemoprotective methods and compositions. The patent has been assigned to BioNumerik Pharmaceuticals Inc., San Antonio. According to an abstract posted by the World Intellectual Property Organization, the invention...